The global mRNA synthesis and manufacturing market is projected to grow from USD 624.4 million in 2024 to USD 738.3 million by 2029, at a CAGR of 3.4%. Key drivers include the growing focus on ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial.

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new study conducted by SISSA's Laboratory of Cerebral Cortex Development and recently published in BMC Biology has led to a ...

Discover the groundbreaking research on microRNA by Nobel Prize winners Ambros and Ruvkun, revolutionizing gene regulation ...

A new study has provided a detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream. The research aimed to help improve the safety and effectiveness of these vaccines, ...

RNA-based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the destruction ...

In the late 1980s, Ambros and Ruvkun were postdoctoral researchers in the laboratory of Robert Horvitz, who received the ...

DELRAY BEACH, Fla., Oct. 16, 2024 /PRNewswire/ -- The global mRNA synthesis and manufacturing market is projected to grow ...

The market is expanding rapidly due to factors such as the development of mRNA-based vaccines and expanded applications such as cancer immunotherapies. Furthermore, improvements in mRNA synthesis ...